Want to join the conversation?
Biotechnology company $TMO said that it has opened a state-of-the-art GMP clinical services facility in Singapore, which will act as a one-stop service in clinical supplies to both regional and global pharma and biotech companies. The new facility will meet the rising demand for clinical supply services in the region.
$BABA seems to be on a roll! But increasing its yearly sales outlook from 48% to 54% seems over-expectation from the company's part, doesn't it?
$JNJ down 2% in pre-market trading. Earnings beat expectations, but sales disappointed. Johnson is cautious on its outlook. How it will perform in the future?